Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 140 Esophageal Neoplasms 71 Pancreatic Neoplasms 42 Esophageal Squamous Cell Carcinoma 26 Carcinoma, Non-Small-Cell Lung 24 Adenocarcinoma Of Esophagus 23 Breast Neoplasms 18 Neoplasms 15 Neoplasm Metastasis 15 Colorectal Neoplasms 15 Prostatic Neoplasms 11 Ovarian Neoplasms 9 Melanoma 9 Squamous Cell Carcinoma of Head and Neck 8 Lung Neoplasms 8 Adenocarcinoma 8 Sarcoma 7 Colonic Neoplasms 7 Biliary Tract Neoplasms 7 Small Cell Lung Carcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Carcinoma, Renal Cell 6 Urinary Bladder Neoplasms 5 Gastrointestinal Neoplasms 5 Gallbladder Neoplasms 5 Carcinoma, Hepatocellular 5 Uterine Cervical Neoplasms 4 Salivary Gland Neoplasms 4 Rectal Neoplasms 4 Head and Neck Neoplasms 4

Interventions

Irinotecan 10 Fluorouracil 10 Leucovorin 9 Bevacizumab 9 Gemcitabine 8 Paclitaxel 7 Cisplatin 7 Capecitabine 7 Oxaliplatin 6 130-nm albumin-bound paclitaxel 6 Albumin-Bound Paclitaxel 5 napabucasin 4 Sorafenib 4 Drug Therapy 4 Cetuximab 4 pembrolizumab 3 apatinib 3 Radiotherapy 3 Ocoxin 3 Imatinib Mesylate 3 Folfox protocol 3 Everolimus 3 tislelizumab 2 spartalizumab 2 palbociclib 2 entinostat 2 encorafenib 2 camrelizumab 2 anlotinib 2 Sunitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Digestive System Neoplasms × Docetaxel × Gastrointestinal × Clear all

NCT05262335 2023-11-28

ALTER-G-001

Ruijin Hospital

Phase 2 Unknown

Gastrointestinal

Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡